Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 161 results.
User Information
Export Records
  1. 1.   Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs
  2. Weingarten-Gabbay, Shira; Klaeger, Susan; Sarkizova, Siranush; Pearlman, Leah R.; Chen, Da-Yuan; Gallagher, Kathleen M. E.; Bauer, Matthew R.; Taylor, Hannah B.; Dunn, W. Augustine; Tarr, Christina; Sidney, John; Rachimi, Suzanna; Conway, Hasahn L.; Katsis, Katelin; Wang, Yuntong; Leistritz-Edwards, Del; Durkin, Melissa R.; Tomkins-Tinch, Christopher H.; Finkel, Yaara; Nachshon, Aharon; Gentili, Matteo; Rivera, Keith D.; Carulli, Isabel P.; Chea, Vipheaviny A.; Chandrashekar, Abishek; Bozkus, Cansu Cimen; Carrington,Mary; Bhardwaj, Nina; Barouch, Dan H.; Sette, Alessandro; Maus, Marcela; Rice, Charles M.; Clauser, Karl R.; Keskin, Derin B.; Pregibon, Daniel C.; Hacohen, Nir; Carr, Steven A.; Abelin, Jennifer G.; Saeed, Mohsan; Sabeti, Pardis C.
  3. CELL. 2021, Jul 22; 184(15): 3962-3980.e17.
  1. 2.   Distinct genetic architectures and environmental factors associate with host response to the gamma 2-herpesvirus infections
  2. Sallah, Neneh; Miley, Wendell; Labo, Nazzarena; Carstensen, Tommy; Fatumo, Segun; Gurdasani, Deepti; Pollard, Martin O; Dilthey, Alexander T; Mentzer, Alexander J; Marshall, Vickie; Cornejo Castro, Elena M; Pomilla, Cristina; Young, Elizabeth H; Asiki, Gershim; Hibberd, Martin L; Sandhu, Manjinder; Kellam, Paul; Newton, Robert; Whitby, Denise; Barroso, Inês
  3. Nature communications. 2020, Jul 31; 11(1): 3849.
  1. 3.   Loss of tetherin antagonism by Nef impairs SIV replication during acute infection of rhesus macaques
  2. Tavakoli-Tameh, Aidin; Janaka, Sanath Kumar; Zarbock, Katie; O'Connor, Shelby; Crosno, Kristin; Capuano, Saverio; Uno, Hajime; Lifson,Jeffrey; Evans, David T
  3. PLoS pathogens. 2020, Apr 17; 16(4): e1008487.
  1. 4.   The NCI Transcriptional Pharmacodynamics Workbench: A Tool to Examine Dynamic Expression Profiling of Therapeutic Response in the NCI-60 Cell Line Panel
  2. Monks, Anne; Zhao, Yingdong; Hose,Curtis; Hamed, Hossein; Krushkal, Julia; Fang, Jianwen; Sonkin, Dmitriy; Palmisano, Alida; Polley, Eric C.; Fogli, Laura K.; Konate, Mariam M.; Miller, Sarah B.; Simpson,Mel; Voth,Andrea; Li, Ming-Chung; Harris,Erik; Wu,Xiaolin; Connelly,John; Rapisarda,Annamaria; Teicher,Beverly; Simon, Richard; Doroshow, James H.
  3. Cancer research. 2018, Dec 15; 78(24): 6807-6817.
  1. 5.   Killer cell immunoglobulin-like receptor 3DL1 variation modifies HLA-B*57 protection against HIV-1
  2. Martin, Pat; Naranbhai, Vivek; Shea, Patrick R.; Qi, Ying; Ramsuran, Veron; Vince, Nicolas; Gao, Xiaojiang; Thomas, Rasmi; Brumme, Zabrina L.; Carlson, Jonathan M.; Wolinsky, Steven M.; Goedert, James J.; Walker, Bruce D.; Segal, Florencia P.; Deeks, Steven G.; Haas, David W.; Migueles, Stephen A.; Connors, Mark; Michael, Nelson; Fellay, Jacques; Gostick, Emma; Llewellyn-Lacey, Sian; Price, David A.; Lafont, Bernard A.; Pymm, Phillip; Saunders, Philippa M.; Widjaja, Jacqueline; Wong, Shu Cheng; Vivian, Julian P.; Rossjohn, Jamie; Brooks, Andrew G.; Carrington, Mary
  3. Journal of Clinical Investigation. 2018, May 01; 128(5): 1903-1912.
  1. 6.   Rapid and Rigorous IL-17A Production by a Distinct Subpopulation of Effector Memory T Lymphocytes Constitutes a Novel Mechanism of Toxic Shock Syndrome Immunopathology
  2. Szabo, Peter A.; Goswami, Ankur; Mazzuca, Delfina M.; Kim, Kyoungok; O'Gorman, David B.; Hess, David A.; Welch, Ian D.; Young, Howard; Singh, Bhagirath; McCormick, John K.; Haeryfar, S. M. Mansour
  3. JOURNAL OF IMMUNOLOGY. 2017, Apr 1; 198(7): 2805-2818.
  1. 7.   HIV-1 Control by NK Cells via Reduced Interaction between KIR2DL2 and HLA-C*12:02/C*14:03
  2. Lin, Zhansong; Kuroki, Kimiko; Kuse, Nozomi; Sun, Xiaoming; Akahoshi, Tomohiro; Qi, Ying; Chikata, Takayuki; Naruto, Takuya; Koyanagi, Madoka; Murakoshi, Hayato; Gatanaga, Hiroyuki; Oka, Shinichi; Carrington, Mary; Maenaka, Katsumi; Takiguchi, Masafumi
  3. CELL REPORTS. 2016, Nov 22; 17(9): 2210-2220.
  1. 8.   Molecular cloning and expression of the IL-10 gene from guinea pigs
  2. Dirisala, V. R.; Jeevan, A.; Bix, G.; Yoshimura, T.; McMurray, D. N.
  3. Gene. 2012, Apr; 498(1): 120-127.
  1. 9.   Psoriasis Patients Are Enriched for Genetic Variants That Protect against HIV-1 Disease
  2. Chen, H. Y.; Hayashi, G.; Lai, O. Y.; Dilthey, A.; Kuebler, P. J.; Wong, T. V.; Martin, M. P.; Vina, M. A. F.; McVean, G.; Wabl, M.; Leslie, K. S.; Maurer, T.; Martin, J. N.; Deeks, S. G.; Carrington, M.; Bowcock, A. M.; Nixon, D. F.; Liao, W.
  3. Plos Genetics. 2012, Feb; 8(2):
  1. 10.   Copy Number Variation of KIR Genes Influences HIV-1 Control
  2. Pelak, K.; Need, A. C.; Fellay, J.; Shianna, K. V.; Feng, S.; Urban, T. J.; Ge, D. L.; De Luca, A.; Martinez-Picado, J.; Wolinsky, S. M.; Martinson, J. J.; Jamieson, B. D.; Bream, J. H.; Martin, M. P.; Borrow, P.; Letvin, N. L.; McMichael, A. J.; Haynes, B. F.; Telenti, A.; Carrington, M.; Goldstein, D. B.; Alter, G.; Vaccine, N. C. H. A.
  3. Plos Biology. 2011, Nov; 9(11):
  1. 11.   Epigenetic regulation of CIITA expression in human T-cells
  2. van Eggermond, M.; Boom, D. R.; Klous, P.; Schooten, E.; Marquez, V. E.; Wierda, R. J.; Holling, T. M.; van den Eisen, P. J.
  3. Biochemical Pharmacology. 2011, Nov; 82(10): 1430-1437.
  1. 12.   Killer cell immunoglobulin-like receptor 3DL1-mediated recognition of human leukocyte antigen B
  2. Vivian, J. P.; Duncan, R. C.; Berry, R.; O'Connor, G. M.; Reid, H. H.; Beddoe, T.; Gras, S.; Saunders, P. M.; Olshina, M. A.; Widjaja, J. M. L.; Harpur, C. M.; Lin, J.; Maloveste, S. M.; Price, D. A.; Lafont, B. A. P.; McVicar, D. W.; Clements, C. S.; Brooks, A. G.; Rossjohn, J.
  3. Nature. 2011, Nov; 479(7373): 401-U155.
  1. 13.   KIR2DL2 Enhances Protective and Detrimental HLA Class I-Mediated Immunity in Chronic Viral Infection
  2. al Basatena, N. K. S.; MacNamara, A.; Vine, A. M.; Thio, C. L.; Astemborski, J.; Usuku, K.; Osame, M.; Kirk, G. D.; Donfield, S. M.; Goedert, J. J.; Bangham, C. R. M.; Carrington, M.; Khakoo, S. I.; Asquith, B.
  3. Plos Pathogens. 2011, Oct; 7(10): 12.
  1. 14.   Human Leukocyte Antigen Genotype and Risk of HIV Disease Progression before and after Initiation of Antiretroviral Therapy
  2. Kuniholm, M. H.; Gao, X. J.; Xue, X. N.; Kovacs, A.; Anastos, K.; Marti, D.; Greenblatt, R. M.; Cohen, M. H.; Minkoff, H.; Gange, S. J.; Fazzari, M.; Young, M. A.; Strickler, H. D.; Carrington, M.
  3. Journal of Virology. 2011, Oct; 85(20): 10826-10833.
  1. 15.   Engineered Single Human CD4 Domains as Potent HIV-1 Inhibitors and Components of Vaccine Immunogens
  2. Chen, W. Z.; Feng, Y.; Gong, R.; Zhu, Z. Y.; Wang, Y. P.; Zhao, Q.; Dimitrov, D. S.
  3. Journal of Virology. 2011, Sep; 85(18): 9395-9405.
  1. 16.   Analysis of Binding of KIR3DS1*014 to HLA Suggests Distinct Evolutionary History of KIR3DS1
  2. O'Connor, G. M.; Yamada, E.; Rampersaud, A.; Thomas, R.; Carrington, M.; McVicar, D. W.
  3. Journal of Immunology. 2011, Sep; 187(5): 2162-2171.
  1. 17.   Ex vivo functional responses to HLA-G differ between blood and decidual NK cells
  2. Apps, R.; Sharkey, A.; Gardner, L.; Male, V.; Kennedy, P.; Masters, L.; Farrell, L.; Jones, D.; Thomas, R.; Moffett, A.
  3. Molecular Human Reproduction. 2011, Sep; 17(9): 577-586.
  1. 18.   Characterization and polymorphic analysis of 4.5 kb genomic full-length HLA-C in the Chinese Han population
  2. Xu, Y.; Deng, Z.; O'HUigin, C.; Wang, D.; Gao, S.; Zeng, J.; Yang, B.; Jin, S.; Zou, H.
  3. Tissue Antigens. 2011, Aug; 78(2): 102-114.
  1. 19.   HIV-1 adaptation to NK-cell-mediated immune pressure
  2. Alter, G.; Heckerman, D.; Schneidewind, A.; Fadda, L.; Kadie, C. M.; Carlson, J. M.; Oniangue-Ndza, C.; Martin, M.; Li, B.; Khakoo, S. I.; Carrington, M.; Allen, T. M.; Altfeld, M.
  3. Nature. 2011, Aug; 476(7358): 96-+.
  1. 20.   Mouse Ly49G2(+) NK cells dominate early responses during both immune reconstitution and activation independently of MHC
  2. Barao, I.; Alvarez, M.; Ames, E.; Orr, M. T.; Stefanski, H. E.; Blazar, B. R.; Lanier, L. L.; Anderson, S. K.; Redelman, D.; Murphy, W. J.
  3. Blood. 2011, Jun; 117(26): 7032-7041.
  1. 21.   HLA-A*7401-Mediated Control of HIV Viremia Is Independent of Its Linkage Disequilibrium with HLA-B*5703
  2. Matthews, P. C.; Adl, E.; Listgarten, J.; Leslie, A.; Mkhwanazi, N.; Carlson, J. M.; Harndahl, M.; Stryhn, A.; Payne, R. P.; Ogwu, A.; Huang, K. H. G.; Frater, J.; Paioni, P.; Kloverpris, H.; Jooste, P.; Goedhals, D.; van Vuuren, C.; Steyn, D.; Riddell, L.; Chen, F.; Luzzi, G.; Balachandran, T.; Ndung'u, T.; Buus, S.; Carrington, M.; Shapiro, R.; Heckerman, D.; Goulder, P. J. R.
  3. Journal of Immunology. 2011, May; 186(10): 5675-5686.
  1. 22.   Factors Associated With Viral Rebound in HIV-1-Infected Individuals Enrolled in a Therapeutic HIV-1 gag Vaccine Trial
  2. Li, J. Z.; Brumme, Z. L.; Brumme, C. J.; Wang, H. Y.; Spritzler, J.; Robertson, M. N.; Lederman, M. M.; Carrington, M.; Walker, B. D.; Schooley, R. T.; Kuritzkes, D. R.; AIDS Clinical Trials Group (ACTG) A5197 Team
  3. Journal of Infectious Diseases. 2011, Apr; 203(7): 976-983.
  1. 23.   Spontaneous Control of HCV Is Associated With Expression of HLA-B*57 and Preservation of Targeted Epitopes
  2. Kim, A. Y.; Kuntzen, T.; Timm, J.; Nolan, B. E.; Baca, M. A.; Reyor, L. L.; Berical, A. C.; Feller, A. J.; Johnson, K. L.; Zur Wiesch, J. S.; Robbins, G. K.; Chung, R. T.; Walker, B. D.; Carrington, M.; Allen, T. M.; Lauer, G. M.
  3. Gastroenterology. 2011, Feb; 140(2): 686-U434.
  1. 24.   HLA/KIR Restraint of HIV: Surviving the Fittest
  2. Bashirova, A. A.; Thomas, R.; Carrington, M.; Paul, W. E.; Littman, D. R.; Yokoyama, W. M.
  3. Annual Review of Immunology. 2011 29: 295-317.
  1. 25.   HLA-Cw group 1 ligands for KIR increase susceptibility to invasive cervical cancer
  2. Martin, M. P.; Borecki, I. B.; Zhang, Z. Y.; Nguyen, L.; Ma, D. D.; Gao, X. J.; Qi, Y.; Carrington, M.; Rader, J. S.
  3. Immunogenetics. 2010, Dec; 62(11-12): 761-765.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel